Production (Stage)
Merck KGaA
MKGAF
$129.80
-$1.65-1.26%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 773.47M | 711.00M | 889.40M | 653.34M | 753.40M |
| Total Depreciation and Amortization | 497.76M | 390.14M | 493.62M | 481.12M | 492.86M |
| Total Amortization of Deferred Charges | -- | 117.26M | -- | -- | -- |
| Total Other Non-Cash Items | 14.73M | 66.09M | 15.39M | 241.10M | -9.77M |
| Change in Net Operating Assets | -700.86M | 27.72M | 204.48M | -448.83M | -112.90M |
| Cash from Operations | 585.10M | 1.31B | 1.60B | 926.73M | 1.12B |
| Capital Expenditure | -512.49M | -434.91M | -501.32M | -340.12M | -567.76M |
| Sale of Property, Plant, and Equipment | 5.26M | -8.53M | 19.79M | 6.46M | 11.94M |
| Cash Acquisitions | -- | -234.51M | -609.05M | -- | -- |
| Divestitures | -- | 1.07M | -- | -- | 6.51M |
| Other Investing Activities | 66.30M | 2.13M | -776.16M | 301.37M | -198.66M |
| Cash from Investing | -440.93M | -674.76M | -1.87B | -32.29M | -747.97M |
| Total Debt Issued | -- | 1.36B | 728.00M | 738.00M | -- |
| Total Debt Repaid | -1.56B | -2.74B | -- | -110.00M | -55.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -48.41M | 0.00 | -- | -1.05B | -56.45M |
| Other Financing Activities | -- | 138.00M | -1.00M | -10.00M | -- |
| Cash from Financing | -1.69B | -1.33B | 799.25M | -387.48M | -116.16M |
| Foreign Exchange rate Adjustments | -42.09M | 3.20M | -13.19M | -5.38M | -2.17M |
| Miscellaneous Cash Flow Adjustments | -- | 1.07M | 1.10M | -1.08M | 1.09M |
| Net Change in Cash | -1.59B | -686.48M | 523.30M | 500.50M | 258.37M |